| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/20/2007 | EP1797035A2 Cyclopropyl piperidine glycine transporter inhibitors |
| 06/20/2007 | EP1610786B1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 06/20/2007 | CN1984895A Synthesis and uses of synephrine derivatives |
| 06/20/2007 | CN1984885A Bicyclic aromatic sulfinyl derivatives |
| 06/20/2007 | CN1984877A Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 06/20/2007 | CN1982298A Hydro diamine compound, its production and use and composition containing it |
| 06/19/2007 | US7232926 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 06/19/2007 | US7232911 Process for the preparation of 2-aminomethylpyridine derivative |
| 06/19/2007 | US7232908 Process for the production of piperidine derivatives with microorganisms |
| 06/19/2007 | US7232837 Decongestants; attention deficit disorders; dietetics; hypotensive agents; competitive binding |
| 06/19/2007 | US7232834 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232690 Adding a target to mixture and forming a complex of target and at least one active chemical substance of the mixture,separating the complex from the inactive chemical substances of the mixture, andeitherliberating and isolating and/or identifying at least one active chemical substance |
| 06/19/2007 | CA2167660C Synergistic stabilizer mixture |
| 06/14/2007 | WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/14/2007 | WO2007065655A1 Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
| 06/14/2007 | WO2007036713A3 Chemical process |
| 06/14/2007 | WO2007005455A3 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 06/14/2007 | WO2006039767A8 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes |
| 06/14/2007 | US20070135644 Process for making donepezil |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135495 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarboxylate gentisate; crystalline acid salt; low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood; cardiovascular diseases, hypotensive agent |
| 06/14/2007 | US20070135489 Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones |
| 06/14/2007 | US20070135488 Amlodipine nicotinate and process for the preparation thereof |
| 06/14/2007 | US20070135483 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 06/14/2007 | US20070135482 Substituted pyrrolidine and related compounds |
| 06/14/2007 | US20070135434 Sulfonyloxy derivatives |
| 06/14/2007 | US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors |
| 06/14/2007 | US20070135423 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 06/14/2007 | US20070135410 3-Aminopyrrolidone derivatives |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070134774 Such as terfenadine carboxylic acid metabolite, 4-(4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl) -alpha-alpha-dimethylphenylacetic acid; side effect reduction of terfenadine arrythmia |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134164 Fentanyl composition for nasal administration |
| 06/14/2007 | CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/13/2007 | EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative |
| 06/13/2007 | EP1795524A1 Cyclic amine derivative or salt thereof |
| 06/13/2007 | EP1794161A2 Muscarinic receptor antagonists |
| 06/13/2007 | EP1794144A2 Processes for prepating n-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and intermediates |
| 06/13/2007 | EP1794129A2 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/13/2007 | EP1794126A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 06/13/2007 | EP1794125A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1179532B1 Process for the production of indole derivatives and intermediates therefor |
| 06/13/2007 | CN1980929A 4-substituted piperidine derivatives |
| 06/13/2007 | CN1980889A Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230110 Hydroxy-, amino-, and mercapto-substituted 1-oxydihydropyridine-2-thiones; and adducts with polyvalent isocyanates, which when polymerized form microcapsule walls; for use in industrial bactericides; chemical resistance |
| 06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229803 Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229557 Providing a racemic mixture comprising d-threo-methylphenidate and l-threo-methylphenidate; treating racemic mixture with dibenzoyl-L-tartrate, supplying l-fenchyloxyacetic acid; treating second mixture with l-fenchyloxyacetic acid; collecting d-threo-methylphenidate |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007063974A1 Process for hydrogenating aromatic ring of aromatic ring compound |
| 06/07/2007 | WO2007063928A1 Novel noncyclic amine carboxamide derivative and salt thereof |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007045551A3 Renin inhibitors nitroderivatives |
| 06/07/2007 | WO2007042422A3 Process for the synthesis of amine ethers |
| 06/07/2007 | WO2006034092A8 Process for production of piperidine derivatives |
| 06/07/2007 | US20070129553 Process for the preparation of glyceraldehyde acetonide |
| 06/07/2007 | US20070129549 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 06/07/2007 | US20070129440 Polypharmacophoric agents |
| 06/07/2007 | US20070129410 Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| 06/07/2007 | US20070129401 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129378 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | US20070129361 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632227A1 5-(arylsulfonyl)-pyrazolopiperidines |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1791846A1 An improved process for the preparation of irinotecan hydrochloride trihydrate |
| 06/06/2007 | EP1791828A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates |
| 06/06/2007 | EP1791817A1 Dpp-iv inhibitors |
| 06/06/2007 | EP1791815A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 06/06/2007 | EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
| 06/06/2007 | EP1451147A4 Amino acid derivatives |
| 06/06/2007 | CN1976911A Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 06/06/2007 | CN1976901A Novel arylamidine derivative, salt thereof, and antifungal containing these |
| 06/06/2007 | CN1976710A Compounds and compositions as cathepsin S inhibitors |
| 06/06/2007 | CN1976584A Chemical compounds |
| 06/06/2007 | CN1974554A Cyclin imide peptidyl metalloprotease inhibitor and its application |
| 06/06/2007 | CN1319958C Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 06/06/2007 | CN1319945C Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 06/06/2007 | CN1319530C Neurotrophic factor production promoter |
| 06/05/2007 | US7226950 Sodium channel modulators |
| 06/05/2007 | US7226935 Hypoglycemic agent |
| 06/05/2007 | US7226933 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 05/31/2007 | WO2007061555A1 Process for synthesizing remifentanil |